June 23, 2022 Press release - Non-regulatory Targovax announces that the FDA has granted authorization to initiate clinical trials with the enhanced TG01 RAS vaccine in the USA
May 27, 2022 Press release - Non-regulatory Targovax announces publication of the two abstracts accepted for poster presentation at ASCO 2022
May 10, 2022 Press release - Non-regulatory Targovax and Oslo University Hospital announce collaboration to test TG mutant RAS vaccination in multiple myeloma
May 3, 2022 Press release - Non-regulatory Targovax ASA: Invitation to presentation of Targovax’s first quarter 2022 results, Thursday 12 May
April 28, 2022 Press release - Non-regulatory Targovax ASA: Two ONCOS-102 abstracts accepted for ASCO
April 26, 2022 Press release - Non-regulatory Targovax to present at 5th Neoantigen Summit Europe in Amsterdam
April 21, 2022 Press release - Non-regulatory Targovax ASA announces the appointment of two new Board Directors
March 9, 2022 Press release - Non-regulatory Targovax ASA: Poster presentation at the AACR Annual Meeting
March 7, 2022 Press release - Non-regulatory Targovax ASA and Agenus announce collaboration on mutant KRAS cancer vaccine adjuvanted with QS-21 STIMULON™
January 17, 2022 Press release - Non-regulatory Targovax granted Patents for ONCOS-102 in combination with chemotherapy in China and Japan
